Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs

Fig. 1

Impact of SIA intensity on cVDPV outbreaks after OPV2 cessation and OPV13 cessation showing the total paralytic incidence (i.e., including paralysis from OPV-related viruses in all reversion stages) in a block with a cVDPV outbreak in the event of insufficient homotypic OPV SIA. a Paralytic incidence due to serotype 2 polioviruses after OPV2 cessation in 2016, with or without tOPV intensification. b Paralytic incidence due to serotype 1 polioviruses after OPV13 cessation in 2019, for different scenarios of SIA frequency between January 1, 2017

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us